Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINE-FOCUS: Finerenone in Heart Failure Patients With Mildly Reduced or Preserved Ejection Fraction
NCT07583173Phase 4Not yet recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- May 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in heart failure (HF), sponsored by National Center for Cardiovascular Disease. Planned start May 2026; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07583173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07583173.